LHRH Agonists Teaching Slides

LHRH agonists are a type of gonadotropin-releasing hormone agonist that can be used to treat a variety of conditions, including precocious puberty, endometriosis, prostate cancer, and breast cancer.


LHRH Agonists Teaching Slides - cover page
Category
Other
Document type
Other
Language
Chinese
Pages
38
File format
PDF
File size
1.3 MB
Published
18 November, 2023
Updated
18 November, 2023
MD5 checksum
0C2C4D41AD647C2520FF8F8AADCEE26A

About this manual

This document is a set of teaching slides (lectures) presented by pharmacists Chen Ye and Lu Caiping on November 9, 2017. It provides a comprehensive overview of Luteinizing Hormone-Releasing Hormone (LHRH) agonists, detailing their physiological mechanisms, clinical indications, and pharmacokinetic profiles. This manual is written in Chinese.

What's inside

  • Mechanism of Action
  • Indications
  • Pharmacokinetics
  • Dosage and Administration
  • Drug Guidance
  • Special Populations
  • Adverse Reactions
  • Contraindications
  • Monitoring
  • Precautions

Frequently asked questions

What are the indications for LHRH agonists?

They are used for precocious puberty, prostate cancer, breast cancer, uterine fibroids, and endometriosis.

How often should LHRH agonists be administered for endometriosis or uterine fibroids?

They should be administered via subcutaneous injection once every 4 weeks.

What is the recommended dosage for Goserelin in treating endometriosis/uterine fibroids?

The recommended dosage is 3.6mg administered subcutaneously in the anterior abdominal wall every 28 days.

Download PDF (1.3 MB)

Also Manuals